World's Best Scientists 2026 revealed!
Godefridus J. Peters

Godefridus J. Peters

D-Index & Metrics

Medicine

D-Index
100
Citations
54737
World Ranking
8130
National Ranking
11

Godefridus J. Peters publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Godefridus J. Peters sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 786 publications — 86th percentile

86% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Godefridus J. Peters D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Godefridus J. Peters sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 100 D-Index — 60th percentile

60% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Godefridus J. Peters is affiliated with Gdańsk Medical University in Poland. Their research output spans a variety of topics within medicine and biochemistry, genetics, and molecular biology, with a considerable focus on oncology and cancer research.

The scientist's primary fields of study include:

  • Medicine
  • Biochemistry, Genetics and Molecular Biology

With a specialization in subfields such as molecular biology and oncology, their work addresses several intricate aspects of cancer biology and treatment. The detailed subfields covered are:

  • Molecular Biology
  • Oncology
  • Cancer Research
  • Pulmonary and Respiratory Medicine
  • Organic Chemistry

The main topics addressed in their research include:

  • Pancreatic and Hepatic Oncology Research
  • Cancer, Hypoxia, and Metabolism
  • Colorectal Cancer Treatments and Studies
  • Biochemical and Molecular Research
  • Lung Cancer Treatments and Mutations
  • Cancer therapeutics and mechanisms
  • Cancer Cells and Metastasis

Recent significant papers authored or coauthored by Godefridus J. Peters include:

  • Lactate Dehydrogenase and its clinical significance in pancreatic and thoracic cancers, 2022, Seminars in Cancer Biology
  • Heterogeneity and plasticity of cancer-associated fibroblasts in the pancreatic tumor microenvironment, 2021, Seminars in Cancer Biology
  • GSK3β as a novel promising target to overcome chemoresistance in pancreatic cancer, 2021, Drug Resistance Updates
  • Cyclin Dependent Kinase-1 (CDK-1) Inhibition as a Novel Therapeutic Strategy against Pancreatic Ductal Adenocarcinoma (PDAC), 2021, Cancers
  • Imidazo[2,1-b][1,3,4]thiadiazoles with antiproliferative activity against primary and gemcitabine-resistant pancreatic cancer cells, 2020, European Journal of Medicinal Chemistry

Frequent coauthors collaborating with Peters comprise:

  • Elisa Giovannetti
  • Ryszard T. Smoleński
  • Patrizia Diana
  • Marika Frańczak
  • Daniela Carbone

The venues where this researcher regularly publishes research include:

  • Nucleosides Nucleotides & Nucleic Acids
  • Cancers
  • Cancer Drug Resistance
  • Expert Opinion on Drug Metabolism & Toxicology
  • International Journal of Molecular Sciences

Best Publications

  • Guidelines for the use and interpretation of assays for monitoring autophagy

    Daniel J. Klionsky;Fabio C. Abdalla;Hagai Abeliovich;Robert T. Abraham

  • Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

    Daniel J. Klionsky;Kotb Abdelmohsen;Akihisa Abe;Joynal Abedin

  • Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

    Daniel J. Klionsky;Kotb Abdelmohsen;Akihisa Abe;Joynal Abedin

  • MRP3, an organic anion transporter able to transport anti-cancer drugs

    M. Kool;M. van der Linden;M. de Haas;G. L. Scheffer

  • Comparison of the sulforhodamine B protein and tetrazolium (MTT) assays for in vitro chemosensitivity testing.

    Yvonne P. Keepers;Paulo E. Pizao;Godefridus J. Peters;Jannette van Ark-Otte

  • Antifolate resistance mediated by the multidrug resistance proteins MRP1 and MRP2.

    Jan Hendrik Hooijberg;Henk J. Broxterman;Marcel Kool;Yehuda G. Assaraf

  • Molecular basis of bortezomib resistance: proteasome subunit beta5 (PSMB5) gene mutation and overexpression of PSMB5 protein

    Ruud Oerlemans;Niels E. Franke;Yehuda G. Assaraf;Jacqueline Cloos

  • MicroRNA-21 in Pancreatic Cancer: Correlation with Clinical Outcome and Pharmacologic Aspects Underlying Its Role in the Modulation of Gemcitabine Activity

    Elisa Giovannetti;Niccola Funel;Godefridus J. Peters;Marco Del Chiaro

  • Induction of thymidylate synthase as a 5-fluorouracil resistance mechanism

    G.J Peters;H.H.J Backus;S Freemantle;B van Triest

  • Determinants of resistance to 2′,2′-difluorodeoxycytidine (gemcitabine)

    Andries M Bergman;Herbert M Pinedo;Godefridus J Peters

  • A 140-kilodalton extracellular protein is essential for the accumulation of Staphylococcus epidermidis strains on surfaces.

    M Hussain;M Herrmann;C von Eiff;F Perdreau-Remington

  • Patient preference and pharmacokinetics of oral modulated UFT versus intravenous fluorouracil and leucovorin: a randomised crossover trial in advanced colorectal cancer.

    MM Borner;Patrick Schöffski;R de Wit;F Caponigro

  • Interaction between cisplatin and gemcitabine in vitro and in vivo.

    G. J. Peters;A. M. Bergman;V. W. T. Ruiz Van Haperen;G. Veerman

  • Basis for effective combination cancer chemotherapy with antimetabolites.

    Godefridus J. Peters;C.L. van der Wilt;C.J.A. van Moorsel;J. R. Kroep

  • 5-Fluorouracil incorporation into RNA and DNA in relation to thymidylate synthase inhibition of human colorectal cancers

    P. Noordhuis;U. Holwerda;C. L. Van der Wilt;C. J. Van Groeningen

  • Synergistic interaction between cisplatin and gemcitabine in vitro.

    Andries M. Bergman;Ruiz van Haperen;Gijsbert Veerman;Catharina M. Kuiper

  • Identification of microRNA-21 as a biomarker for chemoresistance and clinical outcome following adjuvant therapy in resectable pancreatic cancer.

    Jin-Hyeok Hwang;Jin-Hyeok Hwang;Jin-Hyeok Hwang;Johannes Voortman;Johannes Voortman;Elisa Giovannetti;Elisa Giovannetti;Seth M. Steinberg

  • Dose-Finding and Pharmacokinetic Study of Cisplatin, Gemcitabine, and SU5416 in Patients With Solid Tumors

    Bart C. Kuenen;Lee Rosen;Egbert F. Smit;Mandy R.N. Parson

  • Lysosomal sequestration of sunitinib: a novel mechanism of drug resistance

    Kristy J. Gotink;Henk J. Broxterman;Mariette Labots;Richard R. de Haas

  • Mechanisms of synergism between cisplatin and gemcitabine in ovarian and non-small-cell lung cancer cell lines.

    C J A van Moorsel;H M Pinedo;G Veerman;A M Bergman

Frequent Co-Authors

Elisa Giovannetti
Elisa Giovannetti VU University Medical Center
Gerrit Jansen
Gerrit Jansen Amsterdam UMC
H.M. Pinedo
H.M. Pinedo Vrije Universiteit Amsterdam
Yehuda G. Assaraf
Yehuda G. Assaraf Technion – Israel Institute of Technology
Amir Avan
Amir Avan Mashhad University of Medical Sciences
Henk M.W. Verheul
Henk M.W. Verheul Radboud University
Giuseppe Giaccone
Giuseppe Giaccone Cornell University
Frank A.E. Kruyt
Frank A.E. Kruyt University Medical Center Groningen
Henk L. Dekker
Henk L. Dekker University of Amsterdam

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in medicine in the USA doesn't always mean pursuing a traditional medical degree. There are a variety of related online degrees and career pathways that can lead to rewarding roles in healthcare. For those interested in administrative or behind-the-scenes roles, online medical billing and coding schools that accept fafsa can be a smart starting point, offering financial aid and flexible learning options.

If you’re considering a nursing career, it’s worth looking at nursing school without teas test requirements, which can simplify the admissions process. Alternatively, those seeking a leadership position in healthcare may benefit from a healthcare administration online degree, an accelerated option designed for working adults.

Registered nurses who want to advance their clinical practice might explore rn to np bridge programs, which streamline the path from ADN to a master’s degree and nurse practitioner certification. By considering these alternative educational routes, you can find a path that fits your interests, timeline, and financial situation within the vast healthcare industry.

Best Scientists Citing Godefridus J. Peters

Trending Scientists